Regarding EMT, Cultrara et al. showed that the upregulation of glucose-regulated protein 78 (GRP78), which is a homolog of HSP70, reduces the E-cadherin expression in prostate cancer cells via the TGF-β1 pathway and, therefore, enhances the cell’s ability to pass through EMT [68]. The gene discussed is CDH1; the disease is prostate cancer.